Adolescent-Serving Addiction Treatment Facilities in the United States and the Availability of Medications for Opioid Use Disorder.

Adolescent Adolescent health services Medication for addiction treatment Medication for opioid use disorder Medication-assisted treatment Opioid use disorder Substance abuse treatment centers Treatment facilities

Journal

The Journal of adolescent health : official publication of the Society for Adolescent Medicine
ISSN: 1879-1972
Titre abrégé: J Adolesc Health
Pays: United States
ID NLM: 9102136

Informations de publication

Date de publication:
10 2020
Historique:
received: 31 12 2019
revised: 27 02 2020
accepted: 01 03 2020
pubmed: 28 4 2020
medline: 25 6 2021
entrez: 28 4 2020
Statut: ppublish

Résumé

Adolescents with opioid use disorder are less likely than adults to receive medications for opioid use disorder (MOUD), yet we know little about facilities that provide addiction treatment for adolescents. We sought to describe adolescent-serving addiction treatment facilities in the U.S. and examine associations between facility characteristics and offering MOUD, leading to informed recommendations to improve treatment access. This cross-sectional study used the 2017 National Survey of Substance Abuse Treatment Services. Facilities were classified by whether they offered a specialized adolescent program. Covariates included facility ownership, hospital affiliation, insurance/payments, government grants, accreditation/licensure, location, levels of care, and provision of MOUD. Descriptive statistics and logistic regression compared adolescent-serving versus adult-focused facilities and identified characteristics associated with offering maintenance MOUD. Among 13,585 addiction treatment facilities in the U.S., 3,537 (26.0%) offered adolescent programs. Adolescent-serving facilities were half as likely to offer maintenance MOUD as adult-focused facilities (odds ratio, .53; 95% confidence interval, .49-.58), which was offered at 23.1% (816) of adolescent-serving versus 35.9% (3,612) of adult-focused facilities. Among adolescent-serving facilities, characteristics associated with increased unadjusted odds of offering maintenance MOUD were nonprofit status, hospital affiliation, accepting insurance (particularly, private insurance), accreditation, Northeastern location, or offering inpatient services. The one-quarter of U.S. addiction treatment facilities that serve adolescents are half as likely to provide MOUD as adult-focused facilities, which may explain why adolescents are less likely than adults to receive MOUD. Strategies to increase adolescent access to MOUD may consider insurance reforms/incentives, facility accreditation, and geographically targeted funding.

Identifiants

pubmed: 32336560
pii: S1054-139X(20)30106-3
doi: 10.1016/j.jadohealth.2020.03.005
pmc: PMC7508760
mid: NIHMS1576225
pii:
doi:

Substances chimiques

Buprenorphine 40D3SCR4GZ

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

542-549

Subventions

Organisme : NICHD NIH HHS
ID : T32 HD052459
Pays : United States
Organisme : NIDA NIH HHS
ID : K01 DA042139
Pays : United States
Organisme : NIDA NIH HHS
ID : K23 DA045085
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA045872
Pays : United States
Organisme : NIDA NIH HHS
ID : K01 DA035387
Pays : United States
Organisme : NIDA NIH HHS
ID : L40 DA042434
Pays : United States

Informations de copyright

Copyright © 2020 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Rachel H Alinsky (RH)

Division of General Pediatrics and Adolescent Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland. Electronic address: RAlinsk1@jhmi.edu.

Scott E Hadland (SE)

Department of Pediatrics/Grayken Center for Addiction, Boston Medical Center, Boston, Massachusetts; Division of General Pediatrics, Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts.

Pamela A Matson (PA)

Division of General Pediatrics and Adolescent Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.

Magdalena Cerda (M)

Department of Population Health, Center for Opioid Epidemiology & Policy, New York University School of Medicine, New York, New York.

Brendan Saloner (B)

Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH